Since the first discoveries, absence of parafibromin has been associated with diagnostic evidence [57,58,59] and worse prognosis of parathyroid carcinomas [59,60,61] and malignant behaviour of tumours histologically diagnosed as atypical adenomas [40]. The gene discussed is CDC73; the disease is parathyroid gland carcinoma.